# FMC CORPORATION (FMC) · Edgar & Edgarette company card

> Fmc (FMC) saw revenue fall 18.3% in FY2025 to $3.5 billion, operating margin -47.0% against a 0.1% median for chemicals & allied products, equity 21.4% of assets, and its dividend per share fell in the latest year on record. Every figure is from the company’s own annual report filed with the SEC.

SEC CIK 37785 · fiscal year ended 2025-12-31 · 5 audited years read · [page](https://www.pops4.com/boards/company/FMC) · [JSON](https://www.pops4.com/boards/company/FMC.json)

## Figures, as filed in the 10-K

| Measure | Value |
|---|---|
| Revenue | $3.5B |
| Revenue growth, 1 year | -18.3% |
| Revenue growth per year | -8.9% |
| Operating margin | -47.0% (prior year 11.9%) |
| Net margin | -64.6% |
| Operating cash flow | — |
| Capital spending | $96M |
| Free cash flow | — |
| Cash | $585M |
| Long-term debt | $3.4B |
| Total assets | $9.7B |
| Total equity | $2.1B |
| Equity ÷ assets | 21.4% |
| Return on equity | -108.1% |
| Dividend per share | $1.82 |
| Dividend years rising | 0 |

## Readings, computed from those figures

- Altman Z: 1.37 (grey zone)
- Piotroski F: 1 of 9 (weak)
- Health Harbor boat: Old boat · three warning signs · filed restructuring or exit costs, material impairment in the last 12 months; slow and jumpy: growing slower than its size class, with revenue that swings more; operating loss: a margin of -47.0% in FY2025

## Edgarette's reading

Exposure: revenue $3.5B (FY2025), total debt $3.4B. Experience: revenue down 18.3% on the year, down 8.9% a year over 4 years; operating margin -47.0%, down from 11.9%. Soundness: equity 21.4% of assets, return on equity -108.1%, the dividend per share fell in the latest year on record. Credibility: four or more audited years, reasonable weight. Range: 80% of past cases like this landed between $2.3B and $3.5B next year (method v4.1: its own 4-year record of growth weighed at 50% against $1B–10B filers; across 2019–2025, 69.0% landed inside, 83.4% on the one year the method never saw). In a shock year the stress range is $2.0B to $4.0B. A statistical range, not company guidance. Against peers (9 filers, $50M+ revenue, chemicals & allied products): operating margin -47.0% against a 0.1% median; growth -18.3% against 0.4%.

Range logged 2026-09-24, receipt c1b4d77747132590, status open. A statistical range, not company guidance.

## Health Watch, last 12 months

- Item 2.05 Restructuring or exit costs: 1, latest 2025-12-12 ([filing](https://www.sec.gov/Archives/edgar/data/37785/000003778525000134/0000037785-25-000134-index.htm))
- Item 2.06 Material impairment: 1, latest 2025-12-12 ([filing](https://www.sec.gov/Archives/edgar/data/37785/000003778525000134/0000037785-25-000134-index.htm))
- Item 5.02 Director or officer change: 3, latest 2026-10-21 ([filing](https://www.sec.gov/Archives/edgar/data/37785/000095010326015974/0000950103-26-015974-index.htm))

## Recent filings

- 10-Q · filed 2026-10-30 · [filing](https://www.sec.gov/Archives/edgar/data/37785/000003778526000171/0000037785-26-000171-index.htm)
- 8-K · filed 2026-10-29 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/37785/000003778526000168/0000037785-26-000168-index.htm)
- 8-K · filed 2026-10-21 · 5.02 Departure or Election of Directors; Appointment of Officers · [filing](https://www.sec.gov/Archives/edgar/data/37785/000095010326015974/0000950103-26-015974-index.htm)
- 8-K · filed 2026-10-21 · 1.01 Entry into a Material Definitive Agreement; 2.03 Creation of a Direct Financial Obligation; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/37785/000119312526427896/0001193125-26-427896-index.htm)
- 8-K · filed 2026-10-15 · 2.02 Results of Operations and Financial Condition; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/37785/000003778526000149/0000037785-26-000149-index.htm)
- 8-K · filed 2026-09-23 · 1.01 Entry into a Material Definitive Agreement; 3.02 Unregistered Sales of Equity Securities; 7.01 Regulation FD Disclosure; 9.01 Financial Statements and Exhibits · [filing](https://www.sec.gov/Archives/edgar/data/37785/000095010326014390/0000950103-26-014390-index.htm)

## Sources

- facts: https://data.sec.gov/api/xbrl/companyfacts/CIK0000037785.json
- filings: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=37785

## Cite

POPS4, Edgar & Edgarette: FMC CORPORATION (FMC) company card, from the company's own SEC filings, accessed 2026-11-08, https://www.pops4.com/boards/company/FMC. CC BY 4.0. For a figure, add the filing URL under filings or sources.

DOI https://doi.org/10.5281/zenodo.23672509 · catalog https://www.pops4.com/boards/catalog.json · Figures as filed with the SEC. Card text CC BY 4.0, POPS4.

Reporting, not investment advice. No price targets and no trading recommendations.

Figures are as filed in audited 10-K reports and can move with restatements, acquisitions, disposals or a change in fiscal year. A range set from how past company-years turned out is not a promise about the next one, and says nothing about the share price.